Mesa Laboratories Inc
NASDAQ:MLAB
Mesa Laboratories Inc
NASDAQ:MLAB
Price:
105.52 USD
2.26%
Market Closed
Updated:
Apr 30, 2024
Mesa Laboratories Inc
Cash from Operating Activities
|
Mesa Laboratories Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Mesa Laboratories Inc
NASDAQ:MLAB
|
Cash from Operating Activities
$43.8m
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Mesa Laboratories Inc's Cash from Operating Activities?
Cash from Operating Activities
43.8m
USD
43.8m
USD
Based on the financial report for Dec 31, 2023, Mesa Laboratories Inc's Cash from Operating Activities amounts to 43.8m USD.
What is Mesa Laboratories Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
13%
Over the last year, the Cash from Operating Activities growth was 77%. The average annual Cash from Operating Activities growth rates for Mesa Laboratories Inc have been 11% over the past three years , 8% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
